WallStreetZenWallStreetZen

NASDAQ: ARWR
Arrowhead Pharmaceuticals Inc Stock Ownership - Who owns Arrowhead Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Arrowhead Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Hongbo LuDirector2026-05-122,970$76.88
$228.33kSell
James C. HamiltonChief Medical Officer2026-04-2310,000$75.00
$750.00kSell
Daniel Joseph ApelChief Financial Officer2026-04-228,730$71.92
$627.86kSell
Daniel Joseph ApelChief Financial Officer2026-04-221,157$70.45
$81.51kSell
Daniel Joseph ApelChief Financial Officer2026-04-223,208$70.11
$224.91kSell
James C. HamiltonChief Medical Officer2026-03-0510,000$64.19
$641.90kSell
Patrick 1. ObrienCOO2026-01-05313$68.00
$21.28kSell
Patrick 1. ObrienCOO2026-01-05900$66.01
$59.41kSell
Patrick 1. ObrienCOO2026-01-052,700$64.44
$173.99kSell
Patrick 1. ObrienCOO2026-01-0511,842$63.84
$755.99kSell

1 of 7

ARWR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ARWR insiders and whales buy or sell their stock.

ARWR Shareholders

What type of owners hold Arrowhead Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc12.89%18,161,519$1.35BInstitution
Avoro Capital Advisors LLC7.60%10,699,999$797.36MInstitution
Fmr LLC5.16%7,266,652$541.51MInstitution
Vanguard Portfolio Management LLC5.07%7,146,136$532.53MInstitution
State Street Corp4.61%6,496,130$484.09MInstitution
Vanguard Capital Management LLC4.28%6,032,416$449.54MInstitution
David M. Knott3.98%5,609,690$418.03MInsider
Geode Capital Management LLC3.04%4,278,828$318.86MInstitution
Christopher Richard Anzalone2.69%3,792,739$282.63MInsider
Fred Alger Management LLC2.37%3,342,493$249.08MInstitution

1 of 3

ARWR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARWR85.81%9.77%Net SellingNet Selling
BMRN94.99%1.82%Net SellingNet Selling
SMMT8.35%91.65%Net BuyingNet Buying
MDGL26.32%73.68%Net BuyingNet Selling
NUVL77.75%22.25%Net SellingNet Selling
View Top Biotech Stocks

Arrowhead Pharmaceuticals Stock Ownership FAQ

Who owns Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals (NASDAQ: ARWR) is owned by 85.81% institutional shareholders, 9.77% Arrowhead Pharmaceuticals insiders, and 4.42% retail investors. David M. Knott is the largest individual Arrowhead Pharmaceuticals shareholder, owning 5.61M shares representing 3.98% of the company. David M. Knott's Arrowhead Pharmaceuticals shares are currently valued at $418.03M.

If you're new to stock investing, here's how to buy Arrowhead Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.